In line with this, Nox2 knockout and inhibition of NOX2 have shown beneficial effects in models of atherosclerosis, of which the pathology is driven by macrophage-mediated inflammation and oxLDL formation [23,24,25,26]. The gene discussed is CYBB; the disease is atherosclerosis.